Manufacturing BreakthroughsTM

Translating groundbreaking research into life-changing therapies.

Our Story

Landmark BioTM translates groundbreaking research into life-changing medicines. We provide development, manufacturing, and regulatory capabilities to help early-stage life science innovators rapidly progress advanced therapies from bench to clinic.

Launched in 2021, Landmark BioTM is an unprecedented venture bringing together the best of industry, academia and research hospitals to accelerate life sciences innovation. A public benefit company, our work advances emerging technologies, demonstrates therapeutic potential, and improves human health.

Our Core Values

Our Core Values. PASSION. Relentlessly innovate to improve human health. DRIVE. Intrinsically motivated, act with integrity, accountability, and a sense of urgency. FOCUS. Put patients and clients front and center, deliver exceptional services. COMMUNITY. Build an inclusive culture that instills trust, enables growth, empowers, and inspires. FORESIGHT. Anticipate, explore, and set the course for the future. Our Core Values. PASSION. Relentlessly innovate to improve human health. DRIVE. Intrinsically motivated, act with integrity, accountability, and a sense of urgency. FOCUS. Put patients and clients front and center, deliver exceptional services. COMMUNITY. Build an inclusive culture that instills trust, enables growth, empowers, and inspires. FORESIGHT. Anticipate, explore, and set the course for the future. Our Core Values. PASSION. Relentlessly innovate to improve human health. DRIVE. Intrinsically motivated, act with integrity, accountability, and a sense of urgency. FOCUS. Put patients and clients front and center, deliver exceptional services. COMMUNITY. Build an inclusive culture that instills trust, enables growth, empowers, and inspires. FORESIGHT. Anticipate, explore, and set the course for the future.

Our Capabilities

Landmark BioTM provides process development, manufacturing capabilities and consulting services for early-stage life sciences innovators developing advanced therapies such as cell, gene, and RNA medicines.

Our state-of-the-art facility in Watertown, Mass. includes:

  • 4 Cell Processing Suites
  • 2 Viral Vector (Upstream / Downstream) Suites
  • 1 mRNA/LNP Suite
  • 1 Fill/Finish Suite
  • Multiple Process Development Labs
  • Multiple Analytical Development and QC Labs

We offer:

  • Cell & gene therapies, gene editing, mRNA, LNP, non-viral gene delivery
  • Process, analytical & formulation development
  • GMP manufacturing, in-house QC testing
  • CMC development and regulatory consulting
  • Novel manufacturing technology development, evaluation, and de-risking

Our People

Leadership Team

Michael Covington

Michael Covington

CQRO, LANDMARK BIO

View Bio
Gregg Nyberg

Gregg Nyberg

CTO, LANDMARK BIO

View Bio
Ran Zheng

Ran Zheng

CEO, LANDMARK BIO
BOARD MEMBER

View Bio

Board Members

Alan Garber

Alan Garber

PROVOST, HARVARD UNIVERSITY
Board Chair

View Bio
Amanda Halford

Amanda Halford

Vice President Commercial US, Canada, Latin America, Europe and Services

View Bio
Brett Geiger, PhD

Brett Geiger, PhD

Associate – Science & Technology
Alexandria Real Estate Equities, Inc./Alexandria Venture Investments

View Bio
Cynthia Barnhart

Cynthia Barnhart

PROVOST, MIT
BOARD MEMBER

View Bio
Martin Meeson

Martin Meeson

CEO, FUJIFILM DIOSYNTH BIOTECHNOLOGIES
BOARD MEMBER

View Bio
Ran Zheng

Ran Zheng

CEO, LANDMARK BIO
BOARD MEMBER

View Bio

Founding Institutions

Collaborating Institutions

Join Us

We are looking for diverse and mission-driven talent to help us shape the future of human health and turn today’s cutting-edge research into tomorrow’s breakthrough therapies. Please view our open positions below or contact us at careers@landmarkbio.com.

News

Learn more about the exciting developments taking place at Landmark Bio